Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELSA-Adult: Early Stopping of Antibiotics in High Risk Haematological Malignancies
NCT07051525Recruiting
- Sponsor
- Peter MacCallum Cancer Centre
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Peter MacCallum Cancer Centre. Primary endpoint: Empiric Antibiotic Free Days at 28 days. Started Dec 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07051525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07051525.